Michael Lytton's Net Worth
$6.7 Million
Who is Michael Lytton?
Michael Lytton has an estimated net worth of $6.7 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., PATHEON INC, Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc., ACADIA PHARMACEUTICALS INC, Patheon N.V., and Solexa, Inc..
SEC CIK
Michael Lytton's CIK is 0001286396
Past Insider Trading and Trends
2011 was Michael Lytton's most active year for acquiring shares with 8 total transactions. Michael Lytton's most active month to acquire stocks was the month of May. 2010 was Michael Lytton's most active year for disposing of shares, totalling 2 transactions. Michael Lytton's most active month to dispose stocks was the month of February. 2013 saw Michael Lytton paying a total of $380,183.80 for 172,540 shares, this is the most they've acquired in one year. In 2014 Michael Lytton cashed out on 619,030 shares for a total of $5,318,159.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5
EVP Corporate & Business Devel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +77.93% | 8.26K |
$57.31 | -$128,087.85 | 18.87K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PATHEON INC No price found
EVP Corp Dev & Strategy and GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -379.03K |
$9.32 | -$3,532,559.60 |
0
|
Mar 11
| |||
Form 4
| +26.75% | 80K |
$2.01 | $160,800.00 | 379.03K |
Jul 15
| |||
Form 4
| +4.38% | 12.54K |
$3.97 | $49,783.80 | 299.03K |
Jan 14
| |||
Form 4
| +38.74% | 80K |
$2.12 | $169,600.00 | 286.49K |
Jan 4
| |||
Form 4
| +8.00% | 15.29K |
$3.19 | $48,775.10 | 206.49K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +109.65% | 100K |
$1.15 | $115,000.00 | 191.2K |
Dec 23
| |||
Form 4
| +48.78% | 29.9K |
$2.25 | $67,244.00 | 91.2K |
Jun 22 - Jun 23
| |||
Form 4
| +74.15% | 26.1K |
$2.25 | $58,704.00 | 61.3K |
Jun 20 - Jun 21
| |||
Form 4
| +27.08% | 7.5K |
$2.25 | $16,875.00 | 35.2K |
Jun 17
| |||
Form 4
|
∞
| 27.7K |
$2.04 | $56,508.00 | 27.7K |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Trubion Pharmaceuticals, Inc No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +5,180.19% | 2.16M |
—
|
—
| 2.2M |
Oct 23
| |||
Form 4
|
∞
| 41.61K |
$13.00 | $540,982.00 | 41.61K |
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cyberkinetics Neurotechnology Systems, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.58% | 833.33K |
$1.20 | $1,000,000.80 | 10.54M |
Oct 18
| |||
Form 4
| +34.69% | 2.5M |
$1.20 | $3,000,000.00 | 9.71M |
Sep 26
| |||
Form 4
| +4.62% | 318.5K |
$3.00 | $955,503.00 | 7.21M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
| +22.78% | 586.4K |
$6.82 | $4,000,023.96 | 3.16M |
Apr 20
| |||
Form 4
| +112.31% | 2.6M |
$7.00 | $1,995,000.00 | 4.91M |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |